Stay updated on Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial
Sign up to get notified when there's something new on the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page.

Latest updates to the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study content. This indicates the page is blocked due to permission restrictions, preventing viewing the study details.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, blocking access to the NCT01636206 content. The UI presents a generic error page with standard navigation and footer instead of the study information.SummaryDifference17%

- Check17 days agoChange DetectedRevision: v3.7.0 appears instead of v3.6.6, indicating a backend or template update behind the page rather than a change in study content.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page revision stamp was updated to v3.6.6, indicating a minor internal update to the page version without altering study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling an internal update to the page template and related rendering components for the study record.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3. This represents a small software/version update to the page rather than changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page.